Additionally, physicians who lack experience or are uncomfortable prescribing SUD treatments will already have extensive experience prescribing GLP-1s
The data is clear: employers that pair GLP-1 access with advocacy, coaching, and clinical oversight achieve better outcomes and lower overall plan costs
Despite these encouraging trends, the market has hurdles, including due to the high cost of GLP-1 agonists, which may limit access for specific patient populations
A healthcare professional can analyze your results and see how they relate to your overall health and your current treatment plan, including medications
Codes from diagnosis used International Classification of Disease (ICD-10-CM), laboratory tests used Logical Observation Identifiers Names and Codes (LOINC), TriNetX curated codes (TNX), and procedures via Current Procedural Terminology (CPT) codes